“Tobacco plant helps with vaccine against coronavirus” | Financial

BAT claims that its proprietary technology for fast-growing tobacco plants offers a number of advantages in vaccine making. For example, the plants cannot carry germs that can make people sick, and the elements used in vaccines build up faster in the plants than in “conventional methods.” In addition, unlike conventional methods, no cooling is required.

Premature

The study is still in a premature, pre-clinical phase. BAT hopes to produce between 1 and 3 million vaccines every week from June if the tests go well and the right partnerships can be made. BAT says it intends not to make a profit from working on a corona vaccine.

KBP has been part of Reynolds American, an American subsidiary of BAT, since 2014. He bought the biotech company to develop electronic tobacco products. KBP made headlines in 2014 after helping develop an effective Ebola vaccine.

–